|
|
 |
|
New hope for 'antisense' treatments The Nando Times The technique, known as "antisense," aims to kill the genetic messenger carrying diseases. But despite all its promise over the last two decades, the field has brought just one obscure drug to market — treating an eye ailment in AIDS patients — and left numerous failures and jaded researchers in its wake. Now comes antisense's first legitimate shot at success. Cancer patients are taking an experimental drug based on the method, Genasense, in three pivotal trials. The results are expected in the next few months. Scientists, analysts and Genta Inc., the company that makes the drug, are optimistic at least one trial will lead to Food and Drug Administration approval of Genasense.
—Posted: May 26, 2003
More news headlines: This week | Last week | Search archive
|
|
|
